US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

258.49

-0.2795-0.11%

Number of Gainers:7

Number of Losers:8

Number of Flat:1

PE:- -

High:260.36

Open:258.77

Low:258.35

Close:258.63

Volume:2.24M

Turnover:13.73M

Market Cap:63.75B

Float Cap:56.22B

Loading ...

Avecho to Spotlight Phase III CBD Insomnia Trial at Canaccord Conference

Aurora UK Alpha Updates Voting Rights After Treasury Share Buyback

Asian Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live

BNP Paribas Upgrades Dr. Reddy's Laboratories to Outperform Neutral, $14.80 Price Target

MT Newswires Live

Dr. Reddy's Laboratories Rises Monday, Outperforms Competitors

Analysts Offer Insights on Healthcare Companies: Tilray (TLRY) and Hinge Health, Inc. Class A (HNGE)

Teva : Oppenheimer Raises Target Price to $52 from $50

THOMSON REUTERS

Table: Aurora Corp Sep Rev Nt$888.9m vs Nt$869.9m

Aurora Solar Hit With Cease Trade Order Over Delayed Annual Filings

Tilray Brands is Maintained at Hold by Canaccord Genuity

Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says

MT Newswires Live

Teva Pharmaceutical on Track for Highest Close Since February 2017

Teva's Weltruza Seen as Launch-Execution Story After Clean Label, Oppenheimer Says

MT Newswires Live

Tilray Should Benefit from 2H Cannabis Recovery, BrewDog Buy

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down 1% for Week

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults

MT Newswires Live

Teva announces FDA approval for Weltruza

CBD Leasing Enters Sale and Leaseback Contract

MT Newswires Live

Dr. Reddy's Laboratories Rises Friday, Outperforms Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/BK4557/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":258.3546,"timestamp":1791898697493,"preClose":258.63416,"halted":0,"volume":2235072,"delay":0,"changeRate":-0.001081,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.279541,"latestTime":"10-13 09:38:17 EDT","open":258.76904,"high":260.364,"low":258.3546,"amount":13727841.976803,"amplitude":0.007769,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.682236,"peRate":103.34288,"turnoverRate":0.000747,"increases":7,"decrements":8,"flats":1,"marketCap":63751565032,"floatMarketCap":56219863130.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":260.364,"amplitude":0.007781,"preClose":258.63416,"low":258.35147,"pbRate":"3.682236","latestPrice":258.48822,"volume":2235530,"delay":0,"open":258.76904,"prevYearClose":226.48174,"prevWeekClose":257.7512,"prevMonthClose":251.0422,"prevQuarterClose":251.0422,"fiveDayClose":248.39,"twentyDayClose":246.5149,"sixtyDayClose":215.1981,"secType":"PLATE","market":"US","turnoverRate":0.000747,"peRate":103.34288,"marketCap":63751565032,"floatMarketCap":56219863130.5,"timestamp":1791898699870,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":7,"down":8,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675831553","title":"Avecho to Spotlight Phase III CBD Insomnia Trial at Canaccord Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2675831553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675831553?lang=en_us&edition=fundamental","pubTime":"2026-10-13 06:40","pubTimestamp":1791844805,"startTime":"0","endTime":"0","summary":"Avecho Biotechnology Limited ( ($AU:AVE) ) just unveiled an announcement. Avecho Biotechnology will present at the Canaccord Drug and Device Confer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avecho-to-spotlight-phase-iii-cbd-insomnia-trial-at-canaccord-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avecho-to-spotlight-phase-iii-cbd-insomnia-trial-at-canaccord-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACB","MSOS","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675801587","title":"Aurora UK Alpha Updates Voting Rights After Treasury Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2675801587","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675801587?lang=en_us&edition=fundamental","pubTime":"2026-10-13 00:22","pubTimestamp":1791822161,"startTime":"0","endTime":"0","summary":"Aurora Investment Trust PLC ( ($GB:ARR) ) has shared an announcement. Aurora UK Alpha PLC has bought back 25,000 ordinary shares at 247.3707 pence ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-updates-voting-rights-after-treasury-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-updates-voting-rights-after-treasury-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","MSOS","BK4007","ACB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674153805","title":"Asian Equities Traded in the US as American Depositary Receipts Start Week Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2674153805","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674153805?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:40","pubTimestamp":1791816033,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts opened the week lower Monday morning, declining 0.46% to 2,965.63 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by game live-streaming service HUYA  and used car marketplace Uxin , which were up 1.6% and  0.9% respectively.The decliners from North Asia were led by fashion platform MOGU  and LexinFintech , which shed 16% and 8.1% respectively. They were followed by diagnostic imaging centers firm Concord Medical Services  and fintech firm J and Friends , which fell 7.5% and 6.9% respectively.From South Asia, the gainers were led by pharmaceutical company Dr. Reddy's Laboratories  and lender HDFC Bank , which advanced 3.3% and 0.8% respectively. They were followed by telecommunications firm PLDT , which rose 1%.The decliners from South Asia were led by Canaan , which lost 5.6%, followed by telecommunications firm Telekomunikasi Indonesia , which was off 0.3%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0287143357.SGD","BK4558","LU0528227936.USD","BK4557","LU0049112450.USD","LU0868486357.SGD","LU1854103824.USD","BK4505","LU0348744763.USD","BK4595","LU1791710582.SGD","BK4220","BK4532","SG9999014039.USD","BK4207","LU2265009873.SGD","HUYA","LX","LU0630378692.HKD","JF","LU0797268264.HKD","LU0456842615.SGD","BK4132","LU1267930656.SGD","LU0307460401.USD","BK4566","BK4588","SG9999014021.USD","BK4526","BK4531","BK4170","SG9999001069.SGD","LU1805238398.USD","LU0348814723.USD","LU0541502299.USD","LU1235295612.USD","BK4535","IE00B7N09G41.SGD","LU0630378429.USD","BK4115","SG9999014013.SGD","BK4503","SG9999001051.SGD","LU0197773160.USD","LU2177674079.SGD","LU0918141705.HKD","LU0197229882.USD","LU1046422090.SGD","LU1282648689.USD","LU0231203729.USD","BK4122","LU0248272758.USD","BK4509","IE00B0JY6M65.USD","IE00BYTNYM70.SGD","BK4596","LU0390134368.USD","LU1105468828.SGD","LU2279701549.SGD","BK4007","PHI","SGXZ90724238.SGD","LU2226246903.HKD","LU1508157978.USD","HDB","LU0197773673.USD","LU1791710400.SGD","LU0348816934.USD","LU1804176565.USD","LU0536402901.SGD","BK4600","BK4579","MOGU","UXIN","IE0001KFT4U8.USD","BK4523","RDY","LU0708995666.HKD","BK4085","BK4166","BK4563","CAN","LU1854104046.USD","LU2663582299.SGD","BK4585","LU2008162690.USD","CCM","TLK","BK4196","BK4214","LU0431992006.USD","SG9999014005.SGD","LU0541501648.USD","LU0918141887.USD","BK4513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674874701","title":"BNP Paribas Upgrades Dr. Reddy's Laboratories to Outperform Neutral, $14.80 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674874701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674874701?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:23","pubTimestamp":1791804229,"startTime":"0","endTime":"0","summary":"Dr. Reddy's Laboratories (RDY) has an average rating of hold and mean price target of $14.87, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4557","BK4007","LU0348744763.USD","BK4596","RDY.AU","BK4523","BK4532","BK7016","RDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888871","title":"Dr. Reddy's Laboratories Rises Monday, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888871?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:31","pubTimestamp":1791801060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Dr. Reddy's Laboratories Ltd.  rose 2.96% to 1,230.50 Indian rupees Monday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 0.76% to 71,924.68.Dr. Reddy's Laboratories Ltd. closed 13.00% short of its 52-week high of 1,414.40 rupees, which the company reached on June 29th.The stock outperformed some of its competitors Monday, as Lupin Ltd.  fell 1.10% and Zydus Lifesciences Ltd.  rose 1.51%. Wockhardt Ltd.  fell 1.66%.Trading volume totaled 110,740, compared to the 50-day average of 96,311.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","RDY","LU0348744763.USD","BK4523","91335","BK4596","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674757398","title":"Analysts Offer Insights on Healthcare Companies: Tilray (TLRY) and Hinge Health, Inc. Class A (HNGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674757398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674757398?lang=en_us&edition=fundamental","pubTime":"2026-10-12 17:40","pubTimestamp":1791798017,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tilray (TLRY) and Hinge Health, Inc. Class A (HNGE). Tilray (TLRY...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tilray-tlry-and-hinge-health-inc-class-a-hnge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tilray-tlry-and-hinge-health-inc-class-a-hnge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLRY","LU2065169927.USD","BK4557","BK4588","XLV","LABU","LU0128526141.USD","BK4547","HCSG","BK4596","BK4137","LU2065170008.USD","BK4007","BK4585","XBI","BK4196","LU2065171402.SGD","LU0029874061.USD","HNGE","LU2065171311.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674282183","title":"Teva : Oppenheimer Raises Target Price to $52 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2674282183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674282183?lang=en_us&edition=fundamental","pubTime":"2026-10-12 14:07","pubTimestamp":1791785241,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nFWN45Y1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","BK4585","LU1983299246.USD","BK4566","BK4596","BK4584","BK4557","LU2324357040.USD","BK4007","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674920829","title":"Table: Aurora Corp Sep Rev Nt$888.9m vs Nt$869.9m","url":"https://stock-news.laohu8.com/highlight/detail?id=2674920829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674920829?lang=en_us&edition=fundamental","pubTime":"2026-10-12 13:49","pubTimestamp":1791784140,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSOS","BK4557","BK4007","ACB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674867540","title":"Aurora Solar Hit With Cease Trade Order Over Delayed Annual Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2674867540","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674867540?lang=en_us&edition=fundamental","pubTime":"2026-10-10 07:37","pubTimestamp":1791589063,"startTime":"0","endTime":"0","summary":"An announcement from Aurora Solar Technologies ( ($TSE:ACU) ) is now available. Aurora Solar Technologies Inc., a clean technology firm serving glo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-solar-hit-with-cease-trade-order-over-delayed-annual-filings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-solar-hit-with-cease-trade-order-over-delayed-annual-filings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACB","ETEC","CCSO","NTZG","ACES","PBW","CTEC","GSFP","BK4557","MSOS","BK4007","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674664938","title":"Tilray Brands is Maintained at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2674664938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674664938?lang=en_us&edition=fundamental","pubTime":"2026-10-10 02:10","pubTimestamp":1791569400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLRY/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","BK4007","BK4547","TLRY","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674866345","title":"Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2674866345","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674866345?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:32","pubTimestamp":1791567135,"startTime":"0","endTime":"0","summary":"Collegium Pharmaceutical (COLL) should benefit from continued strength in its attention-deficit/hyperactivity disorder drugs, limited near-term generic risk for Belbuca and stable pricing trends, whil","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVC","BK4588","BK4139","LU1983299246.USD","BK4557","BK4559","COLL","BK4566","LU2324357040.USD","BK4007","TEVA","BK4596","BK4585","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674866558","title":"Teva Pharmaceutical on Track for Highest Close Since February 2017","url":"https://stock-news.laohu8.com/highlight/detail?id=2674866558","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674866558?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:32","pubTimestamp":1791567120,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries Limited  is currently at $41.55, up $2.30 or 5.86%--Would be highest close since Feb. 15, 2017, when it closed at $51.06--On pace for largest percent increase since Aug. 12, 2026, when it rose 30.28%--Currently up five of the past six days--Currently up three consecutive days; up 6.18% over this period--Best three-day stretch since the three days ending Aug. 14, 2026, when it rose 30.28%--Up 5.11% this week; best weekly performance since the week ending Sept. 18, 2026, when it rose 5.35%--Up 4.92% month-to-date--Up 45.23% year-to-date; on pace for best year since 2024, when it rose 149.59%--Down 39.99% from its all-time closing high of $69.24 on Sept. 1, 2015--Up 107.65% from 52 weeks ago , when it closed at $20.01--Would be a new 52-week closing high--Up 124.59% from its 52-week closing low of $18.50 on Nov. 12, 2025--Traded as high as $42.02; highest intraday level since Feb. 15, 2017, when it hit $51.06--Up 7.06% at today's intraday high; largest intra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4584","BK4007","LU2324357040.USD","BK4559","BK4585","BK4588","LU1983299246.USD","BK4557","BK4596","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674286523","title":"Teva's Weltruza Seen as Launch-Execution Story After Clean Label, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2674286523","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674286523?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:52","pubTimestamp":1791564767,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  Weltruza approval removes the label risk that defined the long-acting olanzapine debate, leaving launch execution as the key question, Oppenheimer said in a note Friday.With no REMS, no post-injection observation requirement and no boxed warning for post-injection delirium sedation syndrome, Weltruza is the first practical olanzapine LAI, the firm said.Oppenheimer expects a quiet first half of 2027 focused on sampling, hospital formularies and state-by-state Medicaid additions, with meaningful revenue in the second half. It said the launch should be judged on samples, formulary wins and prescriptions, not early sales.The $3,950 monthly list price, 47% above Oppenheimer's initial assumption, signals Teva's confidence in the profile, the firm said. It assumes a 40% gross-to-net discount and flagged rebate depth as the key variable through 2027.Oppenheimer raised its price target to $52 from $50 and reiterated its outperform rating.Price: 41.64, Change: +2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4557","BK4007","LU1983299246.USD","BK4588","BK4585","LU2324357040.USD","BK4559","TEVA","BK4596","BK4566","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674786517","title":"Tilray Should Benefit from 2H Cannabis Recovery, BrewDog Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2674786517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674786517?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:46","pubTimestamp":1791564360,"startTime":"0","endTime":"0","summary":"1246 ET - Tilray Brands still has work to do in its legacy beverage and adult-use cannabis business, but there are green shoots of improvement, according to TD Cowen's Derek Lessard. In a report, the analyst notes that the company is making progress against its key priorities, and that \"we are encouraged by the early performance of its new cannabis strains, alongside improving BrewDog demand and margins.\" It is still early days for these new additions. \"While these trends are still developing, they give us greater confidence in TLRY's longer-term growth outlook,\" Lessard says. He expects recreational cannabis to return to growth in 2H, while the recent acquisition of BrewDog should help lift overall margins above its legacy average.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","YOLO","MSOX","TOKE","WEED","MSOS","TLRY","BK4007","BK4596","MJ","CNBS","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674056850","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down 1% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2674056850","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674056850?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:44","pubTimestamp":1791557057,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking higher Friday morning, rising 0.4% to 2,965.6 on the S&P Asia 50 ADR Index, which is down about 1% for the week so far.From North Asia, the gainers were led by mobile app developer Cheetah Mobile  and automotive marketplace Token Cat , which climbed 13% and 7.8% respectively. They were followed by fashion platform MOGU  and video-sharing site Bilibili , which advanced 3% and 4.5% respectively.The decliners from North Asia were led by commercial real estate and digital security company Eason Technology  and lender Mitsubishi UFJ Financial Group , which dropped 3% and 1.4% respectively. They were followed by lender Sumitomo Mitsui Financial Group  and solar panel maker JinkoSolar , which lost 1.4% and 1% respectively.From South Asia, the gainers were led by computer hardware maker Canaan  and tech conglomerate Sea , which rose 6.5% and 2.8% respectively. They were followed by pharmaceutical company Dr. Reddy's ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TC","LU2065171311.SGD","BK4526","LU0261945553.USD","BK4558","FDNI","LU1770036033.HKD","LU2125910500.SGD","SG9999004360.SGD","MUFG","SG9999014492.USD","LU0048573645.USD","IE00BD6J9T35.USD","BK4077","LU0823039010.USD","IE0034224299.USD","LU2543165471.USD","BK4535","BK4220","BK4122","LU2065170008.USD","BK4531","IE0001KFT4U8.USD","BK4164","SG9999001135.SGD","LU0210637038.USD","LU0348788117.USD","LU0589944569.HKD","BK4523","LU0516422952.EUR","MOGU","BK4141","BK4577","LU0499858602.USD","LU2045819591.USD","BK4509","SG9999013460.SGD","LU0516423174.USD","LU2008162690.USD","BK4009","RDY","BK4504","LU0572939691.SGD","LU0516422366.SGD","LU0979878070.USD","BK4503","JKS","SE","SG9999013478.USD","SG9999002406.SGD","LU0289960550.SGD","LU0441851309.USD","DXF","BK4551","IE0031814969.USD","LU0516423091.SGD","BK4581","LU2360107671.USD","BK4588","BK4513","BK4566","BK4170","LU2238330802.EUR","LU0823038988.USD","SG9999002679.SGD","SMFG","LU0572940350.SGD","BK4085","LU0264606111.USD","BK4557","BK4600","SGXZ58947870.SGD","BK4207","LU0516422440.USD","BK4563","09626","SG9999014484.SGD","SG9999002414.USD","BK4548","CAN","LU0251143029.SGD","LU0532188223.SGD","LU1242518857.USD","BK4532","SG9999006266.SGD","LU2152927971.USD","CMCM","LU0737861269.HKD","LU2125910849.SGD","BK4134","BK4595","LU1861217088.USD","SG9999002620.SGD","BK4585","LU1048588211.SGD","LU0499858438.USD","WIT","LU1839390173.USD","LU0345776255.USD","SG9999002604.SGD","SG9999013486.USD","LU0175139822.USD","BK4519","LU1861220207.SGD","LU0348744763.USD","SG9999005177.SGD","BK4596","LU0345775950.USD","LU2065171402.SGD","BK4505","LU2065169927.USD","BK4510","EDOG","BK4007","BK4554","LU0072462343.USD","BK4023","LU2177674079.SGD","BILI","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851271","title":"Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674851271?lang=en_us&edition=fundamental","pubTime":"2026-10-09 20:11","pubTimestamp":1791547873,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS). Uni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-tilray-tlry-and-viatris-vtrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-united-therapeutics-uthr-tilray-tlry-and-viatris-vtrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4585","LU2087621335.USD","BK4588","LABU","LU0128526141.USD","LU1839511570.USD","BK4139","HCSG","TLRY","LU0029874061.USD","BK4007","BK4581","BK4532","XLV","LU1699723380.USD","XBI","BK4137","BK4583","LU1571399168.USD","VTRS","UTHR","BK4547","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674859554","title":"Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859554?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:36","pubTimestamp":1791545799,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Friday that the US Food and Drug Administration has approved WELTRUZA for extended-release injectable suspension of olanzapine for subcutaneous use as a treatment of schizophrenia in adults.The company said WELTRUZA will be available in the US in the coming weeks in once-monthly subcutaneous injectable doses of 318 mg, 425 mg and 531 mg.The injections will not require loading doses, oral supplementation, or post-injection monitoring, the company said.Teva said approval was based on results from its phase-3 Solaris trial, which showed a significant reduction in illness severity and improvement in personal and social functioning.The company said the treatment's safety profile was consistent with oral olanzapine, while reported adverse events included weight gain, sleepiness, headache, constipation and injection-site reactions.Shares of the company were up 3.4% in Friday's premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4007","BK4584","BK4557","BK4559","BK4566","LABU","BK4585","LU1983299246.USD","BK4588","BK4596","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","FRTY","XLVX","BK4559","MRNX","IYH","MRNY","LFSC","RSPH","TBXU","GDOC","LABU","PINK","BK4585","LU2324357040.USD","IDNA","NVIB","LU1983299246.USD","GNMX","TECB","BK4557","IEIH","BBP","PSCH","BK4596","BK4584","MEDI","SYNB","BMED","IBB","TEVA","BK4566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674185505","title":"CBD Leasing Enters Sale and Leaseback Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2674185505","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674185505?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:58","pubTimestamp":1791543534,"startTime":"0","endTime":"0","summary":"China Development Bank Financial Leasing  agreed to purchase certain vehicles from Shanghai Mingxing Auto Service for around 183 million yuan.The company will then lease the assets back to the lessee for 12 months for a total lease payment of 188.9 million yuan, a Friday bourse filing showed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01606","BK1186","BK4007","MSOS","ACB","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674853044","title":"Dr. Reddy's Laboratories Rises Friday, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674853044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674853044?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:31","pubTimestamp":1791541860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Dr. Reddy's Laboratories Ltd.  advanced 1.28% to 1,195.10 Indian rupees Friday, on what proved to be an all-around positive trading session for the stock market, with the BSE SENSEX Index  rising 1.23% to 72,472.33.Dr. Reddy's Laboratories Ltd. closed 15.50% below its 52-week high of 1,414.40 rupees, which the company reached on June 29th.The stock outperformed some of its competitors Friday, as Lupin Ltd.  rose 1.01% and Zydus Lifesciences Ltd.  rose 0.49%. Wockhardt Ltd.  fell 1.64%.Trading volume totaled 82,380, compared to the 50-day average of 96,761.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91335","RDY","BK4596","LU0348744763.USD","BK4007","BK4532","BK4523","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}]}}